Joint Venture (StemoniX and Atomwise) Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Joint Venture (StemoniX and Atomwise) General Information
Description
Developer of small molecule therapy treatments focused on disovery and development of innovative molecule drug compounds for effective treatment of rare diseases.
Contact Information
Corporate Office
- 13300 67th Avenue North
- Maple Grove, MN 55311
- United States
Corporate Office
- 13300 67th Avenue North
- Maple Grove, MN 55311
- United States
Joint Venture (StemoniX and Atomwise) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Joint Venture (StemoniX and Atomwise) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Joint Venture (StemoniX and Atomwise) FAQs
-
When was Joint Venture (StemoniX and Atomwise) founded?
Joint Venture (StemoniX and Atomwise) was founded in 2019.
-
Where is Joint Venture (StemoniX and Atomwise) headquartered?
Joint Venture (StemoniX and Atomwise) is headquartered in Maple Grove, MN.
-
What industry is Joint Venture (StemoniX and Atomwise) in?
Joint Venture (StemoniX and Atomwise)’s primary industry is Drug Discovery.
-
Is Joint Venture (StemoniX and Atomwise) a private or public company?
Joint Venture (StemoniX and Atomwise) is a Private company.
-
What is Joint Venture (StemoniX and Atomwise)’s current revenue?
The current revenue for Joint Venture (StemoniX and Atomwise) is .
-
Who are Joint Venture (StemoniX and Atomwise)’s investors?
Numerion Labs and StemoniX have invested in Joint Venture (StemoniX and Atomwise).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process